DSM and Roche Vitamins
This article was originally published in The Tan Sheet
Executive Summary
FTC clears $1.89 bil. sale of Roche Vitamins & Fine Chemicals Unit to Dutch firm DSM under terms of proposed consent agreement announced Sept. 23. Agreement calls for combined firm to divest its phytase enzyme business for swine and poultry food to BASF. Public comments are being accepted until Oct. 22, after which FTC will vote to finalize agreement. DSM, Roche must wait for European Commission approval of the merger as well. Deal was first announced in September 2002 (1"The Tan Sheet" Sept. 9, 2002, p. 6)...
You may also be interested in...
DSM To Acquire Leading Position In Vitamin Supply Market With Roche Deal
Dutch life sciences and performance materials producer DSM will enter the vitamin and carotenoid supply business at the top with the planned acquisition of Roche's Vitamins and Fine Chemicals division
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.